David Teo, regional medical director at International SOS, discusses the latest health issue and how organisations can adopt preventative measures as well as educate their employees to identify symptoms and seek medical help early
Many organisations learnt valuable lessons during the Covid-19 pandemic, investing heavily in business continuity plans and infectious control plans. However, with the emergence of a new threat, the mutated mpox Clade 1b, concerns have arisen about whether these contingency plans remain effective.
The World Health Organisation (WHO) has declared the new mpox strain as a Public Health Emergency of International Concern, with cases emerging in Sweden and Thailand. Currently, WHO and national health authorities do not recommend mass vaccination against mpox. Rather, vaccinations are only advised for high-risk populations and those in close contact with confirmed cases.
mpox is caused by an Orthopox virus which spreads differently depending on the clade. Clade I spreads through close physical contact with body fluids and skin lesions, while Clade II spreads through sexual contact. Clade 1b combines the transmission modes of both Clade I and Clade II.
Given these differing transmission modes, the plans developed for Covid-19 remain relevant but must be adjusted to address the specific characteristics of mpox.
Know the signs
First and foremost, organisations need to keep their employees updated on the latest information about mpox, including changes in transmission patterns and preventive measures adopted by different countries. For instance, many countries are implementing border measures, including health screening at ports of entry and health declarations, and it is important for business travellers to be aware of these protocols.
The next step focuses on education and prevention. While mpox is concerning, it is not easily contracted by those who avoid high-risk activities, such as handling animals or coming into close contact with sick individuals during travel. However, the stigma associated with mpox can prevent individuals from seeking medical attention. Unlike Covid-19, those exposed to mpox may hesitate due to its association with sexual transmission.
As such, organisations should engage their employees to address the stigma associated with mpox. Employees need to be well-informed about how mpox spreads, the symptoms to watch for, and the steps to take if they suspect exposure. Moreover, establishing a clear channel of communication empowers employees to take precautions and report concerns early. This is critical in preventing an outbreak.
Prevent the spread
Encouraging employees to maintain good general hygiene practices is also essential, even though masks may not be necessary. Regular cleaning of high-touch surfaces, providing hand sanitisers, and encouraging frequent handwashing can significantly reduce transmission risk.
While mpox may not spread as rapidly as Covid-19, office environments where close contact is common – such as workplaces and communal areas – remain vulnerable. The incubation period for mpox can be up to 21 days, meaning individuals may unknowingly carry and spread the virus before symptoms appear.
To mitigate these risks, businesses should conduct detailed risk assessments to identify areas where employees are likely to be in close contact. These assessments should inform targeted preventive measures, such as modifying office layouts, reducing in-person meetings, and limiting large gatherings. Organisations like International SOS can also assist in conducting these risk assessments and developing tailored strategies to help businesses protect their employees and operations effectively.
In addition to physical measures, flexible work arrangements can play a crucial role in managing mpox risk. Encouraging employees who show symptoms or have been in contact with an infected individual to work from home or take sick leave can prevent the virus from spreading within the workplace. This approach safeguards health and ensures business continuity.
While mpox may not pose the same level of threat as Covid-19, it still requires attention. By adjusting plans, educating staff, and maintaining good hygiene practices, businesses can protect operations and employees from potential disruptions caused by mpox. The lessons learned from past pandemics should guide businesses in navigating this new challenge with confidence.
David Teo oversees the assistance services provided by International SOS Assistance Centres across Asia and heads expert teams of Coordinating Doctors and Nurses in these Assistance Centres.
